ARPIs Beneficial in Prostate Cancer

Researchers compared outcomes for patients randomized to receive androgen receptor pathway inhibitors, taxanes, or a physician's choice.
Medscape Medical News

source https://www.medscape.com/viewarticle/androgen-receptor-pathway-inhibitors-show-improved-outcomes-2024a1000g2n?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?